Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
71
datasets available to search
ShareScore release 0.9.0
Dataset results
71 results for “Therapeutic outcome”
Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes
ClinicalTrials.gov study NCT04567628. IPD Sharing: YES. Countries: 1. Publications: 1.
Feasibility and metabolic outcomes of a well-formulated ketogenic diet as an adjuvant therapeutic intervention for women with stage IV metastatic breast cancer: The Keto-CARE trial
<p><em>Purpose:</em></p> <p>Ketogenic diets may positively influence cancer through pleiotropic mechanisms, but only a few small and short-term studies have addressed feasibility and efficacy in cancer patients. The primary goals of this study were to evaluate the feasibility and the sustained metabolic effects of a personalized well-formulated ketogenic diet (WFKD) designed to achieve consistent blood beta-hydroxybutyrate (<span>β</span>HB) >0.5 mM in women diagnosed with stage IV metastatic breast cancer (MBC) undergoing chemotherapy.</p> <p><em>Methods: </em></p> <p>Women (n = 20) were enrolled in a six-month two-phase, single-arm WFKD intervention (NCT03535701). Phase I was a highly-supervised, ad libitum, personalized WFKD, where women were provided with ketogenic-appropriate food daily for three-months. Phase II transitioned women to a self-administered WFKD with ongoing coaching for an additional three-months. Fasting capillary <span>β</span>HB and glucose were collected daily; weight, body composition, plasma insulin, and insulin resistance were collected at baseline, three- and six-months. </p> <p><em>Results:</em></p> <p>Capillary <span>β</span>HB indicated women achieved nutritional ketosis (Phase I mean: 0.8 mM (n = 15); Phase II mean: 0.7 mM (n = 9)). Body weight decreased 10% after three-months, primarily from body fat. Fasting plasma glucose, plasma insulin, and insulin resistance also decreased significantly after three-months (p < 0.01), an effect that persisted at six-months.</p> <p><em>Conclusions</em>:</p> <p>Women diagnosed with MBC undergoing chemotherapy can safely achieve and maintain nutritional ketosis, while improving body composition and insulin resistance, out to six-months.</p>
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics
ClinicalTrials.gov study NCT02316678. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
ClinicalTrials.gov study NCT01913340. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Feasibility and metabolic outcomes of a well-formulated ketogenic diet as an adjuvant therapeutic intervention for women with stage IV metastatic breast cancer: The Keto-CARE trial
Open the record for dataset details and reuse information.
Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19
ClinicalTrials.gov study NCT04377997. IPD Sharing: NO. Countries: 1. Publications: 20.
Differences in Predicted Therapeutic Outcome of Oral Appliance Determined by RCMP in Quebec Versus Shenyang Patients With OSA.
ClinicalTrials.gov study NCT03231254. IPD Sharing: UNDECIDED. Countries: 2. Publications: 2.
The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup
ClinicalTrials.gov study NCT01680744. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia
ClinicalTrials.gov study NCT03024021. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Diabetic Macular Edema: Relevance of Staging Progression on Therapeutic Outcome
ClinicalTrials.gov study NCT05080803. IPD Sharing: NO. Countries: 1. Publications: 2.
Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients
ClinicalTrials.gov study NCT05298670. IPD Sharing: Not stated. Countries: 1. Publications: 19.
Clinical Outcomes Related to Treatment of Distal Symmetric Polyneuropathy Using Semiconductor Embedded Therapeutic Socks
ClinicalTrials.gov study NCT06452914. IPD Sharing: UNDECIDED. Countries: 1. Publications: 18.
PROMAD: Predicting Therapeutic Outcome of Mandibular Advancement Device Treatment in Obstructive Sleep Apnea
ClinicalTrials.gov study NCT01532050. IPD Sharing: Not stated. Countries: 1. Publications: 5.
The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients
ClinicalTrials.gov study NCT03770559. IPD Sharing: NO. Countries: 1. Publications: 8.
OUTcomes Evaluation of Current Therapeutic STrategies for Severe Aortic Valve steNosis anD the agING Population in ITALY
ClinicalTrials.gov study NCT05778773. IPD Sharing: NO. Countries: 1. Publications: 10.
TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden
ClinicalTrials.gov study NCT07107477. IPD Sharing: UNDECIDED. Countries: 1. Publications: 12.
Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome.
ClinicalTrials.gov study NCT04640324. IPD Sharing: YES. Countries: 1. Publications: 23.
Effect of Xenon and Therapeutic Hypothermia, on the Brain and on Neurological Outcome Following Brain Ischemia in Cardiac Arrest Patients
ClinicalTrials.gov study NCT00879892. IPD Sharing: Not stated. Countries: 2. Publications: 7.
Long-term Surgical Therapeutic Outcomes of Peri-Implantitis
ClinicalTrials.gov study NCT03772652. IPD Sharing: UNDECIDED. Countries: 1. Publications: 25.
Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome
ClinicalTrials.gov study NCT02854046. IPD Sharing: NO. Countries: 0. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.